# Calabar Capital

> Calabar Capital is building an allocator-led, specialist multi-manager investment platform intended to provide institutionally constructed exposure to the precision-health transition, with women's health as its leading edge.

Calabar Capital is currently in development and is not presently offering any investment product. The site sets out the firm's investment thesis (the Precision Premium), its intended investment approach, why it is being built as a specialist multi-manager platform, its insights programme, leadership and contact details.

## Pages

- [/](/): Home — thesis, intended approach, why Calabar, insights, about and contact.

## Sections

- [Our Thesis](/#thesis): The Precision Premium — moving beyond population averages towards biological precision.
- [The Leading Edge](/#womens-health): Why women's health is the leading indicator of the precision-health transition.
- [Where Precision May Create Value](/#precision-premium): Biological specificity, better information, earlier intervention, more precise care.
- [Our Work](/#work): Research, manager assessment and portfolio construction.
- [Why Calabar](/#why-calabar): Allocator-led by design.
- [Insights](/#insights): Calabar Insights — the thinking behind the platform.
- [About](/#about): Platform overview and leadership (Maryann Selfe, Jillian MacNab).
- [Contact](/#contact): Enquiries, Zurich office and contact form.